Press Release: Opella reaches study milestone for Cialis
Portfolio Pulse from
Opella, Sanofi's Consumer Healthcare business, announced that the FDA has lifted a clinical hold on its trial to switch Cialis from prescription to over-the-counter status.
January 21, 2025 | 6:15 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Sanofi's Consumer Healthcare business, Opella, has received FDA approval to proceed with a trial for switching Cialis to over-the-counter status, potentially expanding its market reach.
The FDA lifting the clinical hold allows Sanofi to proceed with trials that could lead to Cialis being available over-the-counter. This could significantly increase sales and market reach, positively impacting Sanofi's stock.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80